0 115

Cited 0 times in

Updated analyses from the CROWN study of first-line lorlatinib vs crizotinib in Asian patients with ALK-positive non-small cell lung cancer (NSCLC)

Authors
 Z. Qing  ;  H.R. Kim  ;  R.A. Soo  ;  C.H. Chiu  ;  H. Hayashi  ;  S-W. Kim  ;  S. Teraoka  ;  D-W. Kim  ;  H. Zhan  ;  H. Zhao  ;  H. Li  ;  T.S.K. Mok  ;  Y-L. Wu 
Citation
 ANNALS OF ONCOLOGY, Vol.33(Supplement 7) : S1007, 2022-09 
Journal Title
ANNALS OF ONCOLOGY
ISSN
 0923-7534 
Issue Date
2022-09
Full Text
https://www.sciencedirect.com/science/article/pii/S0923753422029702
DOI
10.1016/j.annonc.2022.07.1119
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194793
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links